Hericium erinaceus Mycelium Ameliorates In Vivo Progression of Osteoarthritis

Nutrients. 2022 Jun 23;14(13):2605. doi: 10.3390/nu14132605.

Abstract

Osteoarthritis (OA) is an age-related disorder that affects the joints and causes functional disability. Hericium erinaceus is a large edible mushroom with several known medicinal functions. However, the therapeutic effects of H. erinaceus in OA are unknown. In this study, data from Sprague-Dawley rats with knee OA induced by anterior cruciate ligament transection (ACLT) indicated that H. erinaceus mycelium improves ACLT-induced weight-bearing asymmetry and minimizes pain. ACLT-induced increases in articular cartilage degradation and bone erosion were significantly reduced by treatment with H. erinaceus mycelium. In addition, H. erinaceus mycelium reduced the synthesis of proinflammatory cytokines interleukin-1β and tumor necrosis factor-α in OA cartilage and synovium. H. erinaceus mycelium shows promise as a functional food in the treatment of OA.

Keywords: Hericium erinaceus; anterior cruciate ligament transection; interleukin 1 beta; mycelium; osteoarthritis; tumor necrosis factor-alpha.

MeSH terms

  • Animals
  • Cartilage, Articular*
  • Disease Models, Animal
  • Hericium
  • Mycelium
  • Osteoarthritis, Knee* / drug therapy
  • Osteoarthritis, Knee* / pathology
  • Rats
  • Rats, Sprague-Dawley

Supplementary concepts

  • Hericium erinaceus